CSPC Pharmaceutical Group Ltd/ HK1093012172 /
| 31.05.2024 10:08:02 | Diff. -0,20 | Volumen | Geld10:08:03 | Brief10:08:03 | Marktkapitalisierung | Dividendenr. | KGV |
|---|---|---|---|---|---|---|---|
| 6,63HKD | -2,93% | 119,79 Mio. Umsatz: 771,38 Mio. |
6,63Geld Vol: 1,02 Mio. | 6,64Brief Vol: 20.000 | 80,42 Mrd.HKD | - | - |
Aktiva
|
2019 Unknown in Mio. CNY |
2020 HKFRS in Mio. CNY |
2021 HKFRS in Mio. CNY |
2022 HKFRS in Mio. CNY |
2023 HKFRS in Mio. CNY |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sachanlagen | 8.459,2000 | 7.770,4400 | 8.529,3700 | 9.582,0600 | 10.416,5990 | ||||||
| Immaterielle Vermögensgegenstände | 1.135,7000 | 508,7400 | 467,8500 | 1.908,1100 | 2.198,5490 | ||||||
| Finanzanlagen | 1.077,9000 | 35,4100 | 33,6900 | 62,7400 | 1.527,8680 | ||||||
| Anlagevermögen | 12.621,4000 | 14.148,8400 | 14.405,0700 | 17.812,6100 | 19.537,2250 | ||||||
| Vorräte | 2.535,7000 | 1.861,0700 | 2.480,3700 | 2.554,8600 | 3.138,6640 | ||||||
| Forderungen | 2.258,8000 | 2.398,8600 | 3.309,1500 | 3.937,9700 | 5.869,2230 | ||||||
| Liquide Mitteln | 4.118,2000 | 7.296,0300 | 9.283,6400 | 10.298,0100 | 12.015,2230 | ||||||
| Umlaufvermögen | 13.697 | 15.921,3700 | 20.336,5000 | 23.957,1600 | 26.744,9450 | ||||||
| Aktiva, gesamt | 26.318,2000 | 30.070,2100 | 34.741,5800 | 41.769,7700 | 46.282,1700 | ||||||
Passiva
|
2019 Unknown in Mio. CNY |
2020 HKFRS in Mio. CNY |
2021 HKFRS in Mio. CNY |
2022 HKFRS in Mio. CNY |
2023 HKFRS in Mio. CNY |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Verbindlichkeiten aus Lieferungen und Leistungen | 1.110,9000 | 1.204,5700 | 1.481,3600 | 1.507,9900 | 2.426,1150 | ||||||
| Langfristige Schulden | - | - | - | 28,9500 | - | ||||||
| Verbindlichkeiten gegenüber Kreditinstituten | 23 | - | - | - | - | ||||||
| Rückstellungen | 563,2000 | 320,4400 | 381,4800 | 611,9900 | 574,8430 | ||||||
| Verbindlichkeiten | 6.800,2000 | 6.969,1300 | 7.913,3500 | 10.127,9000 | 11.264,1580 | ||||||
| Gezeichnetes Kapital | 10.899,4120 | - | - | - | - | ||||||
| Eigenkapital | 19.518,2000 | 22.332,2900 | 25.986,6700 | 30.197,5300 | 33.203,2080 | ||||||
| Minderheitenanteile | 1.056,4000 | 768,7900 | 841,5600 | 1.444,3400 | 1.814,8040 | ||||||
| Passiva, gesamt | 26.318,2000 | 30.070,2100 | 34.741,5800 | 41.769,7700 | 46.282,1700 | ||||||
Gewinn- und Verlustrechnung
|
2019 Unknown in Mio. CNY |
2020 HKFRS in Mio. CNY |
2021 HKFRS in Mio. CNY |
2022 HKFRS in Mio. CNY |
2023 HKFRS in Mio. CNY |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 22.103,2000 | 24.942,2000 | 27.866,8700 | 30.936,9000 | 31.450,1090 | ||||||
| Abschreibungen (Gesamt) | - | - | - | - | - | ||||||
| Betriebsergebnis | 4.600,2000 | - | - | - | - | ||||||
| Zinsergebnis | -32,4000 | - | - | - | - | ||||||
| Ergebnis vor Steuern | 4.626,2000 | - | - | - | - | ||||||
| Ertragsteuern | 892,8000 | 1.162,0100 | 1.158,9700 | 1.350,2100 | 1.316,6790 | ||||||
| Gewinnanteil Minderheitsgesellschafter | -19,2000 | -69,3600 | 82,9400 | 140,6600 | 199,3680 | ||||||
| Konzernjahresüberschuss | 3.714,1000 | 5.159,6600 | 5.605,1900 | 6.091,3900 | 5.873,3250 | ||||||
Pro Aktie
Cash Flow
|
2019 Unknown in Mio. CNY |
2020 HKFRS in Mio. CNY |
2021 HKFRS in Mio. CNY |
2022 HKFRS in Mio. CNY |
2023 HKFRS in Mio. CNY |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow aus laufender Geschäftstätigkeit | 3.783,9000 | 6.739,6100 | 4.636,6300 | 7.627,0600 | 4.178,8150 | ||||||
| Cash Flow aus Investitionstätigkeit | -2.457,2000 | -2.129,5100 | -637,3300 | -6.795,9800 | 607,2670 | ||||||
| Cash Flow aus Finanzierungstätigkeit | -1.545,5000 | -1.470,9800 | -2.196,6100 | -1.904,0700 | -2.300,9810 | ||||||
| Veränderung der liquiden Mittel | -218,8000 | - | - | - | - | ||||||
| Anzahl der Mitarbeiter | 17.300 | - | - | - | 23.500 | ||||||
